Limited access to cancer biomarker testing in Europe, report finds
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
The EU has unveiled plans for greater Health Technology Assessment harmonisation this week – and put the potential benefits for life sciences centre stage.
New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
FDA agrees to recognise some EU inspections for the first time